Owing to the significant and unequivocal implications of Lp-PLA2 on the initiation and progression of atherosclerosis and CAD, we speculated that increased plasma level of Lp-PLA2 at baseline might contribute to re-stenosis in patients with stent placement. The gene discussed is PLA2G7; the disease is atherosclerosis.